The clinical decision in long-term treatment of anxiety disorders with benzodiazepines

Author： Pancheri P.   Biondi M.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 248-248

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Benzodiazepines remain `mainstay' of treatment for anxiety disorders

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 250, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Lithium long-term treatment in mood disorders: clinical and genetic predictors

By Serretti Alessandro  

Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. : 117-129

Future Medicine

Access to resources Recommend Favorite

Editorial: Are We in Need for Novel Therapeutics in Anxiety Disorders? (Thematic Issue: Non-Antidepressant Long Term Treatment of Anxiety Disorders)

By  

Current Clinical Pharmacology, Vol. 10, Iss. 2, 2015-01 ,pp. : 84-85

Bentham Science Publishers

Access to resources Recommend Favorite

Antidepressants are the main options for the long-term pharmacological treatment of generalized anxiety disorder

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

Tapering Off Benzodiazepines in Long-Term Users: An Economic Evaluation

By Voshaar Richard C. Oude  

PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. : 683-694

Adis International

Access to resources Recommend Favorite